ozempic semaglutide or tirzepatide vs. Semaglutide: Key Differences & Benefits Semaglutide vs Tirzepatide: Head-to-Head for

Some digital health companies see opportunities to tackle metabolic health by offering holistic, longitudinal care

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

Retatrutide is a multi-receptor peptide agonist targeting GLP-1, GIP, and glucagon receptors, designed for advanced metabolic research

Human data (from a meta-analysis of 894 participants) show fenugreek supplementation (0.5 g to 10 g daily over 4 weeks to 6 months) reduces fasting glucose, post-meal glucose, and HbA1c

This study 1) highlights the role of cholesterol in regulating GLP-1R responses in vivo

Understanding your genetic predispositions and biomarker profile may help inform personalized treatment decisions with your provider